Cybin Inc. share price logo

Cybin Inc.

NASDAQ: HELP

Small Cap

$7.25

+0.21

(+2.98%)

as on

Cybin Inc. Stock Performance

as on July 18, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $6.77
    $7.38
    downward going graph

    6.62%

    Downside

    1.79%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Cybin Inc. share price movements today

Previous Close
$7.04
Open
$6.99
Volume
3.7M
Day's Low - High
$6.77 - $7.38

Cybin Inc. Historical Returns

1 Month Return
+ 55.25 %
3 Month Return
+ 31.82 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Cybin Inc. Stock Fundamentals & Key Indicators

Check Cybin Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$403.5M

EPS (TTM)

-4.265

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-74.60%

Cybin Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cybin Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Cybin Inc. image
Cybin Inc.
NA$403.5MNANA0.00%NA
Revolution Medicines Inc. image
Revolution Medicines Inc.
BUY$38.1B524.49%NA0.00%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$123.4B140.09%28.3235.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$71.2B16.02%16.2329.65%0.54%

Indian Investors' Interest in Cybin Inc. Stock

Search interest for Cybin Inc. Stock has increased by 265% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:265% versus previous 30 day period

Cybin Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
1
Gross Profit
0
0
-
0
0
0
1
Operating Income
-57
-32
-33
-24
-40
-41
-47
EBITDA
-57
-32
-
-24
-40
-41
-47
Interest Expense
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
Income Before Tax
-56
-10
-30
-24
-47
-42
-46
Income Tax Expense
-
-
-
-
-
-
15
Net Income
-56
-7
-21
-24
-47
-42
-46
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-3617.82%

Cybin Inc. Annual Profit & Loss

All numbers in Millions USD

Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Total Revenue
0
0
0
-13
0
-44
Gross Profit
0
0
0
-13
0
-44
Operating Income
-31
-63
-51
-78
-143
-141
EBITDA
-30
-63
-51
-78
-142
-141
Interest Expense
0
0
-
-
-
4
Depreciation
-
0
0
0
0
0
Income Before Tax
-32
-67
-47
-78
-113
-57
Income Tax Expense
-
0
0
36
0
89
Net Income
-32
-53
-34
-57
-78
-147
Net Profit Margin
-3729.17%
-40314.14%
-18919.19%
430.23%
-23956.00%
329.09%

Cybin Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-21
-10
-56
-10
-50
-18
-47
-42
-46
Operating Cash Flow
-20
-19
-25
-26
-21
-21
-48
-31
-36
Investing Cash Flow
0
0
0
0
-
0
0
0
0
Financing Cash Flow
190
0
0
0
20
40
0
143
0
Change in Cash
169
-20
-26
-28
-1
18
-48
111
-36

Cybin Inc. Annual Cash Flow

All numbers in Millions USD

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Income
0
0
0
-32
-67
-47
-78
-113
-147
Operating Cash Flow
0
0
0
-19
-45
-47
-68
-101
-132
Investing Cash Flow
0
0
0
-1
0
-3
6
-1
-1
Financing Cash Flow
0
-
0
82
35
13
254
20
196
Change in Cash
0
0
0
62
-10
-37
192
-73
63

Global Institutional Holdings in Cybin Inc.

Funds
Holdings
Orbimed Advisors, LLC
7.68%
Sphera Funds Management Ltd.
1.98%
Citadel Advisors Llc
1.76%
Adage Capital Partners Gp LLC
1.4%
DCF Advisers, LLC
1.39%
See all

Cybin Inc. News & Key Events

  • img

    Today's Timeline - 25 June

    Thu, 08:34 PM

    -

    Helus Pharma closes US$50 million offering of 10,309,280 common shares at US$4.85 each to fund mental health drug development.

Insights on Cybin Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, HELP stock has moved up by 55.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 386.1% return, outperforming this stock by 399.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 593.9% return, outperforming this stock by 648.6%

About Cybin Inc.

Cybin Inc., doing business as Helus Pharma, a clinical stage pharmaceutical company, focuses on developing therapies to treat various psychiatric and neurological conditions.It develops HLP003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and HLP004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders. The company' preclinical product includes HLP005, a phenethylamine and tryptamine derivative to treat central nervous system. It has a strategic partnership agreement with Segal Trials to evaluating HLP003 for the adjunctive treatment of major depressive disorder; and with Osmind for mental health treatments. The company is headquartered in Toronto, Canada.
OrganisationCybin Inc.
Headquarters100 King Street West, Toronto, ON, Canada, M5X 1C9
IndustryBiotechnology
CEOMr. Eric So L.L.B.
E-voting on sharesClick here to vote

Key Management of Cybin Inc.

Name

Title

Mr. Eric So L.L.B.

Co-Founder, Interim CEO, President & Executive Chairman

Mr. Paul Glavine

Co-Founder, Chief Growth Officer & Director

Mr. Gabriel Fahel

Chief Legal Officer & Corporate Secretary

Mr. John Kanakis

Co-Founder

Mr. Aaron Bartlone

Chief Operating Officer

Dr. Alex L. Nivorozhkin Ph.D.

Chief Scientific Officer

Sara Brittany Somerset

Chief Communications Officers

Mr. Greg Cavers

Chief Financial Officer

Mr. George Tziras

Chief Business Officer

Ms. Lori Challenger

Chief Compliance, Ethics & Administrative Officer

FAQs

What is Cybin Inc. share price today?

Cybin Inc. share price today is $7.25 as on at the close of the market. Cybin Inc. share today touched a day high of $7.38 and a low of $6.77.

What is the 52 week high and 52 week low for Cybin Inc. share?

Cybin Inc. share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Cybin Inc. stock price today i.e. is closed at $7.25,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Cybin Inc.'s market capitalisation today?

Cybin Inc. market capitalisation is $0.00T as on .

How to invest in Cybin Inc. Stock (HELP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cybin Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cybin Inc. Shares that will get you 0.2069 shares as per Cybin Inc. share price of $7.25 per share as on July 18, 2026 at 8:46 am IST.

What is the minimum amount required to buy Cybin Inc. Stock (HELP) from India?

Indian investors can start investing in Cybin Inc. (HELP) shares with as little as ₹96.28 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹962.80 in Cybin Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Cybin Inc. share’s latest price of $7.25 as on July 18, 2026 at 8:46 am IST, you will get 1.3793 shares of Cybin Inc.. Learn more about fractional shares .